Talphera (TLPH) Revenue (2011 - 2025)
Talphera's (TLPH) quarterly Revenue came in at $1000.0 in Q3 2025, down 96.3% quarter-over-quarter from $27000.0 in Q1 2025.
Talphera (TLPH) Revenue (2011 - 2025) Analysis & Trends
Talphera's Revenue history runs 14 years deep, the most recent figure standing at $1000.0 for Q3 2025.
- On a quarterly basis, Revenue changed N/A year-over-year to $1000.0 in Q3 2025; TTM through Mar 2026 was $1000.0, a 96.3% decrease from a year earlier, with the FY2025 full-year figure at $28000.0, changed N/A from the prior year.
- Revenue fell to $1000.0 in Q3 2025 per TLPH's latest filing, from $27000.0 in the prior quarter.
- Across five years, Revenue topped out at $1.7 million in Q3 2021 and bottomed at $1000.0 in Q3 2025.
- The 4-year median for Revenue is $281000.0 (2023), against an average of $388909.1.
- Biggest YoY gain for Revenue was 32.38% in 2021; the steepest drop was 99.73% in 2021.
- Year by year, Revenue stood at $2000.0 in 2021, then soared by 22000.0% to $442000.0 in 2022, then plunged by 36.43% to $281000.0 in 2023, then sank by 99.64% to $1000.0 in 2025.
- Per Business Quant, the three latest TLPH Revenue figures stand at $1000.0 (Q3 2025), $27000.0 (Q1 2025), and $281000.0 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Talphera | 94.61 Mn | 56.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2023 | 281,000.00 |
| Sep 30, 2023 | 117,000.00 |
| Jun 30, 2023 | 253,000.00 |
| Mar 31, 2023 | 501,000.00 |
| Mar 31, 2022 | 442,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 1.70 Mn |
| Jun 30, 2021 | 443,000.00 |
| Mar 31, 2021 | 511,000.00 |
| Dec 31, 2020 | 738,000.00 |
| Sep 30, 2020 | 1.37 Mn |
| Jun 30, 2020 | 2.92 Mn |
| Mar 31, 2020 | 386,000.00 |
| Dec 31, 2019 | 475,000.00 |
| Sep 30, 2019 | 608,000.00 |
| Jun 30, 2019 | 941,000.00 |
| Mar 31, 2019 | 265,000.00 |
| Dec 31, 2018 | 613,000.00 |